The Friends of the German Cancer Research Center (DKFZ) support the DKFZ and aim to help strengthen its position in the international arena. With the DKFZ Innovation Award, presented at this year’s…
Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt, partner site Frankfurt/Mainz of the German Cancer Consortium (DKTK), have identified how particularly aggressive forms…
A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients. Researchers from the German Cancer Research Center (DKFZ), Mannheim University…
As of July 1, 2026, Shalini Saxena assumed the role of Administrative Director of the DKFZ on an interim basis. She succeeds Ursula Weyrich, who is moving to ZDF (Second German Television) in Mainz.
Through its “Proof of Concept” (PoC) grants, the European Research Council (ERC) supports scientists in further developing the economic potential of their research findings. In 2026, two scientists…
The European Research Council (ERC) supports visionary projects in basic research through its “Advanced Grants.” This year, the Council awarded a grant to cancer researcher and physician Dieter Saur…
Experts in Heidelberg have developed an AI system that can classify brain tumors with unprecedented accuracy using standard microscopic tissue sections. Using digitized standard stains, the system…
The German Centers for Health Research (DZG) are a group of eight research centers with institutes spread across Germany that are tasked by the German government to combat common diseases. Their…
The 13th Munich Cancer Retreat (MCR13), held on May 19-20, 2026 at the Evangelische Akademie Tutzing, once again brought together scientists, clinicians, physician scientists, and early career…
Scientists from the German Cancer Research Center (DKFZ), the HI-STEM Stem Cell Institute and the German Cancer Consortium (DKTK) have deciphered a key mechanism that contributes to treatment failure…
The Berlin DKTK Community Meeting took place on February 27, 2026 at the Rahel Hirsch Center for translational medicine in Berlin-Mitte. Approximately 120 scientists and doctors came together to…
In aggressive lymphomas, inflammatory messengers reprogram the “conductors” of the immune system, causing lymph nodes structure to collapse. A team led by Simon Haas, scientist at the German Cancer…
The University Children's Hospital Zurich and the Thomas and Doris Ammann Foundation have awarded the Thomas and Doris Ammann Prize to Stefan Pfister, Director of the Hopp Children's Cancer Center…
Award for Prof. Dr. Robert Zeiser / Research on stem cell transplantation and immunotherapy improves treatment for cancer patients / The prize is endowed with 100,000 euros
HARPOON is organized by the DKFZ/NCT/DKTK MASTER-team of the NCT Heidelberg and is intended to provide a platform for exchange and networking and to foster interaction between the One NCT, the DKTK,…
What happens in the brain after radiotherapy? Why do many brain tumor patients still struggle with undesirable consequences of therapy, even years after recovery? Are there ways to prevent these and…
Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation…
On January 27, 2026, researchers from all eight DKTK partner sites convened at the BDC Meeting Space in Heidelberg for the Scientific Community Meeting within DKTK Pillar 2 “Diagnostic Innovations &…
The DZG Innovation Fund (DZGIF) is a joint research funding program of the German Centers for Health Research (DZG). Each call for proposals has a specific research topic. To be eligible for funding,…
Turning research results into innovations: that is the stated goal of the European Research Council’s (ERC) Proof of Concept Grants. With CHECKVIR, a project that builds on ERC-funded research is…